MOH — authorised 19 May 2009
- Marketing authorisation holder: OTSUKA AMERICA PHARM
- Status: likely_approved
MOH authorised Samsca on 19 May 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 19 May 2009.
OTSUKA AMERICA PHARM holds the Israeli marketing authorisation.